Inventor
SABNIS STACI
US16 patents
Patents
16 patentsUS10207010B2Feb 19, 2019
Compositions and methods for delivery of agents
MODERNATX INC104 citations98
US9925277B2Mar 27, 2018
Polynucleotide compositions containing amino acids
MODERNATX INC26 citations92
US11285222B2Mar 29, 2022
Compositions and methods for delivery of agents
MODERNATX INC10 citations85
US11001861B2May 11, 2021
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1
MODERNATX INC11 citations84
US10556018B2Feb 11, 2020
Compositions and methods for delivery of agents
MODERNATX INC6 citations83
US10485885B2Nov 26, 2019
Compositions and methods for delivery of agents
MODERNATX INC8 citations83
US11969506B2Apr 30, 2024
Lipid nanoparticle formulation
MODERNATX INC8 citations80
US10258698B2Apr 16, 2019
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
MODERNATX INC12 citations79
US11649461B2May 16, 2023
Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease
MODERNATX INC1 citations71
US10993918B2May 4, 2021
Polynucleotides encoding citrin for the treatment of Citrullinemia type 2
MODERNATX INC2 citations71
US10519455B2Dec 31, 2019
Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease
MODERNATX INC1 citations71
US10494636B2Dec 3, 2019
Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease
MODERNATX INC3 citations71
US12491260B2Dec 9, 2025
Compositions and methods for delivery of agents
MODERNATX INC0 citations62
US12252704B2Mar 18, 2025
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1
MODERNATX INC0 citations61
US12239742B2Mar 4, 2025
Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2
MODERNATX INC0 citations61
US12377136B2Aug 5, 2025
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
MODERNATX INC0 citations59